Hoping to stop the shenanigans of drug companies that game the system to keep the U.S. market to themselves, the Senate Judiciary Committee voted 16-5 Thursday to send the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act to the Senate floor.